Pharma world braces for major changes in new era of AI

In the aftermath of the Covid-19 pandemic, a new surge in artificial intelligence (AI) technology is beginning to jolt the pharma industry once again. At the Outsourcing in Clinical Trials East Coast conference, the message was clear: trial sponsors and service providers must embrace the change, or risk becoming obsolete.